Alan Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the ACR Board of Chancellors, explains how the ACR and group purchasing organizations are asking the FDA to mitigate the contrast shortage with an emergency use authorization to allow non-FDA cleared iodine contrast agents to be imported.

A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

Football players whose heads are repeatedly struck but suffer no concussions have white-matter abnormalities similar to those sustained by their concussed peers. 

A federal judge has dismissed a class-action lawsuit filed by patients over a data breach at a four-location radiology practice and its countrywide parent company.

The American Hospital Association is asking GE Healthcare to more fully apprise AHA’s nearly 5,000 member organizations of what the company is doing to help ameliorate the ongoing disruption in supplies of Omnipaque (iohexol).